USPTO serial 90700093
XPECT INX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- FROMM, MARTHA L
- Law office
- TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with XPECT INX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Clifford D Hyra
CLIFFORD D HYRA FRESH IP PLC11710 PLAZA AMERICA DRIVE SUITE 2000RESTON, VA 20190UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Polymers for use in the manufacture of industrial and medicinal products, medical devices, consumer and household products, sealants, and inks; Formulations based on polymers, namely, polymers and polymeric additives for use in the in the manufacture of industrial products and medicinal products, medical devices, consumer and household products, sealants, and inks; Formulations based on prepolymers, namely, polymer resins, unprocessed; Polymers and formulations for use as hydrogels, bio-inks and materials, namely, polymer-based compositions and polymer-based filaments for use in manufacturing, namely, additive manufacturing; Chemical components, namely, chemicals for use in industry | ACTIVE | — |
| 002 | Polymer based inks; inks contained in cartridges; bio-inks | ACTIVE | — |
| 005 | Polymers for use in medical applications, namely, chemical reagents for tissue engineering applications, cell culture devices and medical devices; Formulations based on polymers for use in medical applications, namely, chemical reagents for tissue engineering applications, cell culture devices and medical devices; Formulations based on prepolymers for use in medical applications, namely, hydrogel for medical purposes; Chemical components for use in medical applications, namely, chemical reagents for medical or veterinary purposes | ACTIVE | — |
| 017 | Plastic filaments for 3D printing | ACTIVE | — |
| 035 | Wholesale and retail store services featuring unprocessed polymers, polymers for use in industrial applications, polymers for use in the manufacture of household products, polymer based formulations, Formulations based on pre-polymers, polymers and formulations for use as hydrogels, bio-inks and materials, Chemical components, inks, polymer based inks, inks contained in cartridges, bio-inks, polymers for use in medical applications, Polymer based formulations for use in medical applications, formulations based on prepolymers for use in medical applications, chemical preparations for use in medical applications and plastic filaments for 3D printing | ACTIVE | — |
| 041 | Training in the field of unprocessed polymers, polymers for use in industrial applications, polymers for use in the manufacture of household products, polymer based formulations, Formulations based on pre-polymers, polymers and formulations for use as hydrogels, bio-inks and materials, Chemical components, inks, polymer based inks, inks contained in cartridges, bio-inks, polymers for use in medical applications, Polymer based formulations for use in medical applications, formulations based on prepolymers for use in medical applications, chemical preparations for use in medical applications and plastic filaments for 3D printing; advice in relation to the aforementioned services | ACTIVE | — |
| 042 | Scientific research services in the field of unprocessed polymers, polymers for use in industrial applications, polymers for use in the manufacture of household products, polymer based formulations, Formulations based on pre-polymers, polymers and formulations for use as hydrogels, bio-inks and materials, Chemical components, inks, polymer based inks, inks contained in cartridges, bio-inks, polymers for use in medical applications, Polymer based formulations for use in medical applications, formulations based on prepolymers for use in medical applications, chemical preparations for use in medical applications and plastic filaments for 3D printing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by UNIVERSITEIT GENT
- Other trademarks in Class 001
- Other trademarks in Class 002
- Other trademarks in Class 005
- Other trademarks in Class 017
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named XPECT INX
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 11, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 28, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 28, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 13, 2021 | NWAP | NEW APPLICATION ENTERED | — |